Patient-derived organoids in disease modelling
Drug Target Review
OCTOBER 16, 2023
How can PDOs revolutionise drug discovery and deepen our understanding of disease? Patient-derived organoids (PDOs) are proliferative 3D cell structures derived from tissue samples of both healthy and diseased tissue. What sets PDOs apart from traditional 2D cell and animal models used in drug discovery?
Let's personalize your content